Know Labs Approves Key Amendments at Stockholder Meeting

Know Labs ( (KNW) ) just unveiled an update.

On July 31, 2025, Know Labs, Inc. held a Special Meeting of Stockholders where several key amendments were approved. These included increasing the number of shares available in the company’s Equity Incentive Plan by 48,950,000 shares and amending the Articles of Incorporation to increase authorized shares from 7.5 million to 750 million. These changes are aimed at enhancing the company’s financial flexibility and supporting future growth initiatives. Additionally, stockholders approved a private placement proposal and an amendment to the incentive plan, which could significantly impact the company’s capital structure and control dynamics.

Spark’s Take on KNW Stock

According to Spark, TipRanks’ AI Analyst, KNW is a Underperform.

Know Labs faces significant financial and operational challenges, reflected in a low overall score. Key factors include negative financial performance due to substantial losses and high leverage, alongside weak technical indicators. Valuation metrics further underscore the stock’s unattractiveness given its negative P/E ratio and absence of dividends. Without any positive earnings call or corporate events to offset these issues, the stock remains a high-risk investment at this time.

To see Spark’s full report on KNW stock, click here.

More about Know Labs

Know Labs, Inc. operates in the technology industry, focusing on developing and commercializing non-invasive medical diagnostics. The company is known for its innovative products that utilize electromagnetic energy to analyze molecular signatures, with a market focus on healthcare and wellness sectors.

Average Trading Volume: 5,349,737

Technical Sentiment Signal: Sell

Current Market Cap: $20.69M

Learn more about KNW stock on TipRanks’ Stock Analysis page.